Role of Inflammation in Progressive Multifocal Leukoencephalopathy (PML)

NCT01132053 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 126

Last updated 2023-08-14

No results posted yet for this study

Summary

This is a continuation of our previous studies on Progressive Multifocal Leukoencephalopathy (PML). We will focus on the role of inflammation in PML, and define prognostic markers of disease evolution.

Conditions

  • Progressive Multifocal Leukoencephalopathy

Sponsors & Collaborators

Principal Investigators

  • Chen S Tan, MD · Beth Israel Deaconess Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2016-09-30
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01132053 on ClinicalTrials.gov